Here, we explored a novel therapeutic effect of α1-adrenoceptor (α1-AR) blockage on lipopolysaccharide (LPS)-induced myocardial fibrosis and clarified that its molecular mechanism was related to the restoration of CHIP expression. The gene discussed is STUB1; the disease is Myocardial fibrosis.